Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-06-16

FDA Approved: SEVELAMER HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' generic sevelamer hydrochloride for the treatment of hyperphosphatemia in adults and pediatric patients with chronic kidney …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sevelamer hydrochloride (sevelamer hydrochloride)

Snippet

ORIG AP for SEVELAMER HYDROCHLORIDE (SEVELAMER HYDROCHLORIDE)